African countries including Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique have begun a locally-led HIV vaccine research and development.
Reports say the initiative aims to harness and catalyze African scientists to contribute to an African-led effective HIV vaccine
This initiative is under the consortium called ‘Bringing Innovation to Clinical and Laboratory Research to End HIV in Africa through New Vaccine Technology’ (BRILLIANT) led by the Chief Executive Officer and President of the South African Medical Research Council, Cape Town, South Africa, Glenda Gray.
The Executive Director of the International Research Centre of Excellence at the Institute of Human Virology Nigeria and Principal Investigator in Nigeria, Alash’le Abimiku, noted that the objective of the consortium was to evaluate HIV vaccine candidates emanating from the continent.
